CHEMICAL/BIOLOGICAL DEFENSE (RDT&E MGT SUPPORT)

Abstract

This program element (PE) resources research, development, test, and evaluation (RDT&E) management support as a key enabler across the Enabling Investments, Mitigate, Protect, and Understand portfolios. Chemical Biological Defense Program (CBDP) investments provide an integrated, layered capability to enable combating weapons of mass destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The Projects in this PE support sustainment and modernization of laboratory infrastructure, test capabilities, studies and analyses, Joint doctrine and training, and program and financial management support. FY23 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual Projects include: - Major Range and Test Facility Base (MRTFB) (DW6): Operating support to West Desert Test Center (WDTC) and BioTesting Division (Chemical Biological Center) for the required institutional test operating costs (e.g. institutional civilian and contractor labor; repair and maintenance of test instrumentation, equipment, and facilities; and replacement of test equipment). - Laboratory Support (LS6): Operating support for sustainment and modernization efforts for surety laboratory infrastructure in order to maintain and enhance DoD infrastructure capabilities to counter an expanding threat space, exploit advances in technology; and develop and transition CB defense equipment and countermeasures to the Warfighter. - Management Support (MS6): Management support for the DoD CBDP to allow program overview and integration of overall medical and non-medical programs by the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs (ASD(NCB)), through the Deputy Assistant Secretary of Defense for Chemical Biological Defense (DASD(CBD)). - Joint Doctrine and Training Support (DT6) and Joint Concept Development (O49) are no longer active FY23 Projects due to budget restructure.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0605384BP_6_0400_PB_2023
Change Summary Explanation
Funding: FY 2021 (-$0.855 Million): Below threshold reprogramming adjustments to balance overall portfolio efforts. FY 2021 (-$1.641 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2021 (+$5.000 Million) and FY 2022 (+$5.000 Million): Congressional Add for chemical/biological defense testing. FY 2021 Congressional Add is reflected in the Current President's Budget. FY 2023: Funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding. Funding includes specific increases for enhanced biodefense and pandemic preparedness investments (+$7.000 Million) and Departmental inflation rate adjustments (+$4.292 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Biological Sciences
  • Business Administration
  • Chemical Biological Radiological And Nuclear Defense
  • Chemical Warfare Agents
  • Chemical Weapons
  • Command And Control
  • First Responders
  • Homeland Defense
  • Infectious Diseases
  • National Security
  • Risk Analysis
  • Supply Chain
  • Test And Evaluation
  • Test Equipment
  • Test Facilities
  • Unified Combatant Commands
  • Weapons Of Mass Destruction

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology
  • Space

Related Documents